US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

REX CRYPTO EQUITY PREMIUM INCOME ETF

28.06

-1.0112-3.48%

Post-market: 28.070.0065+0.02%19:15 EDT

Volume:112.31K

Turnover:3.19M

Market Cap:79.70M

PE:- -

High:28.90

Open:28.90

Low:27.96

Close:29.07

52wk High:43.70

52wk Low:27.96

Shares:2.84M

Float Shares:2.84M

Volume Ratio:3.08

T/O Rate:3.95%

Dividend:15.79

Dividend Rate:56.27%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

How Investors May Respond To Cognizant Technology Solutions (CTSH) Securing CEPI’s Digital Transformation Partnership

Simply Wall St.

Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CEPI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CEPI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEPI\",,,,,undefined,":{"symbol":"CEPI","market":"US","secType":"STK","nameCN":"REX CRYPTO EQUITY PREMIUM INCOME ETF","latestPrice":28.0635,"timestamp":1774641600000,"preClose":29.0747,"halted":0,"volume":112311,"hourTrading":{"tag":"盘后","latestPrice":28.07,"preClose":28.0635,"latestTime":"19:15 EDT","volume":547,"amount":15374.501,"timestamp":1774653325222,"change":0.0065,"changeRate":0.000232,"amplitude":0.001069},"delay":0,"changeRate":-0.034779378635033165,"floatShares":2840000,"shares":2840000,"eps":0,"marketStatus":"Market Closed","change":-1.0112,"latestTime":"03-27 16:00:00 EDT","open":28.9,"high":28.9,"low":27.96,"amount":3190971.371742,"amplitude":0.032331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":29.0747,"sharesOutstanding":2715000,"nav":29.04,"aum":82473600,"dividendRate":0.562692,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":28.84,"preClose":29.0747,"latestTime":"09:29 EDT","volume":918,"amount":26520.4692,"timestamp":1774618199063,"change":-0.2347,"changeRate":-0.008072,"amplitude":0.033018},"postHourTrading":{"tag":"盘后","latestPrice":28.07,"preClose":28.0635,"latestTime":"19:15 EDT","volume":547,"amount":15374.501,"timestamp":1774653325222,"change":0.0065,"changeRate":0.000232,"amplitude":0.001069},"volumeRatio":3.077769810000679,"impliedVol":0.1812,"impliedVolPercentile":0.2709},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEPI\",,,,,undefined,":{"symbol":"CEPI","floatShares":2840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.077769810000679,"shares":2840000,"dividePrice":15.7911,"high":28.9,"amplitude":0.032331,"preClose":29.0747,"low":27.96,"week52Low":27.96,"pbRate":"--","week52High":43.7,"institutionHeld":0,"latestPrice":28.0635,"eps":0,"divideRate":0.562692,"volume":112311,"delay":0,"ttmEps":0,"open":28.9,"prevYearClose":33.6685,"prevWeekClose":30.36,"prevMonthClose":30.93,"prevQuarterClose":33.6685,"fiveDayClose":30.36,"twentyDayClose":30.93,"sixtyDayClose":33.9511},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CEPI\",params:#limit:5,,,undefined,":[{"date":"2026-03-24","symbol":"CEPI","amount":1.06435,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-25"},{"date":"2026-02-24","symbol":"CEPI","amount":1.1137,"announcedDate":"2026-02-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-24","defaultRemindTime":1771943400000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-25","payableDate":"2026-02-24","currency":"USD","dateTimestamp":1771909200000,"payDate":"2026-02-25"},{"date":"2026-01-27","symbol":"CEPI","amount":1.2516,"announcedDate":"2026-01-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-27","defaultRemindTime":1769524200000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-28","payableDate":"2026-01-27","currency":"USD","dateTimestamp":1769490000000,"payDate":"2026-01-28"},{"date":"2025-12-23","symbol":"CEPI","amount":1.2327,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2025-11-26","symbol":"CEPI","amount":1.22815,"announcedDate":"2025-11-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-26","defaultRemindTime":1764167400000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-26","currency":"USD","dateTimestamp":1764133200000,"payDate":"2025-11-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CEPI\",market:\"US\",,,undefined,":[{"executeDate":"2025-01-28","recordDate":"2025-01-28","paymentDate":"2025-01-29","value":1.69835,"currency":"USD"},{"executeDate":"2025-02-25","recordDate":"2025-02-25","paymentDate":"2025-02-26","value":1.57775,"currency":"USD"},{"executeDate":"2025-03-25","recordDate":"2025-03-25","paymentDate":"2025-03-26","value":1.45915,"currency":"USD"},{"executeDate":"2025-04-29","recordDate":"2025-04-29","paymentDate":"2025-04-30","value":1.3286,"currency":"USD"},{"executeDate":"2025-05-29","recordDate":"2025-05-29","paymentDate":"2025-05-30","value":1.3881,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CEPI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CEPI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607773516","title":"SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family","url":"https://stock-news.laohu8.com/highlight/detail?id=2607773516","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607773516?lang=en_us&edition=fundamental","pubTime":"2026-01-29 10:10","pubTimestamp":1769652600,"startTime":"0","endTime":"0","summary":"Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family. Next-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle technology. SK bioscience will continue to strengthen a Mid- to Long-Term global vaccine strategy centered on universal vaccines for future pandemic preparedness. SK bioscience aims to develop a universal vaccine capable of inducing broad immune responses across the entire virus family and is establishing a platform applicable to multiple related viruses and variants.","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2872245/Photo_1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2872245/Photo_1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/sk-bioscience-initiates-international-phase-12-clinical-trial-of-universal-vaccine-candidate-targeting-sarbecovirus-family-302673365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4075","IPD.AU","BK7509","BK7007","UVV","CEPI"],"gpt_icon":0},{"id":"2585027438","title":"How Investors May Respond To Cognizant Technology Solutions (CTSH) Securing CEPI’s Digital Transformation Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2585027438","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585027438?lang=en_us&edition=fundamental","pubTime":"2025-11-24 05:18","pubTimestamp":1763932723,"startTime":"0","endTime":"0","summary":"On November 20, 2025, the Coalition for Epidemic Preparedness Innovations (CEPI) announced the selection of Cognizant Technology Solutions to deliver a multi-year digital transformation program, including implementing a new HR and Expense Management System and consolidating support for CEPI's Salesforce platform.\nThis collaboration underscores Cognizant's increasing recognition for expertise in enterprise architecture, platform implementation, and AI-enabled automation in the healthcare and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8031000-choice2-main-header/1585186598236","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8031000-choice2-main-header/1585186598236"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-ctsh/cognizant-technology-solutions/news/how-investors-may-respond-to-cognizant-technology-solutions","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-ctsh/cognizant-technology-solutions/news/how-investors-may-respond-to-cognizant-technology-solutions","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0950375773.USD","BK4588","CEPI","BK4134","CTSH","LU1267930656.SGD","LU0072462343.USD","BK4528","LU0821914370.USD","BK4023","ISBC","LU0823417737.USD","BK4585","BK4543","LU0231203729.USD","LU0536402901.SGD","LU2087621335.USD","LU2506951875.HKD","LU2506951958.HKD","AI","BK4551","LU0823417653.USD","LU1048588211.SGD","LU2506952097.USD","LU1839511570.USD","BK4587","LU0708995666.HKD","LU0006061336.USD","LU2506952170.USD","BK4211","LU1048596156.SGD"],"gpt_icon":0},{"id":"2575784366","title":"Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2575784366","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575784366?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:00","pubTimestamp":1760529600,"startTime":"0","endTime":"0","summary":"Seasoned clinician and R&D leader brings extensive experience in translational medicine, drug development, and infectious disease researchWESTLAKE VILLAGE, Calif., Oct.  15, 2025  (GLOBE NEWSWIRE) -- ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/15/3167031/0/en/Turn-Therapeutics-Appoints-Dr-Kent-Kester-to-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEPI","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CEPI\",params:#limit:6,delay:false,,,undefined,":[]}}